Classics in Total Synthesis II is the long awaited sequel to Classics in Total Synthesis, a book that has made an indelible mark as a tool for educating students and practitioners alike in the art of organic synthesis since its introduction in 1996. In this highly welcomed new volume, K. C. Nicolaou and Scott A. Snyder discuss in detail the most impressive accomplishments in natural product total synthesis during the 1990s and the early part of the 21st century. While all of the features that made the first volume of Classics so popular and unique as a teaching tool have been maintained, in this new treatise the authors build upon that model by presenting the latest techniques and advances in organic synthesis as they beautifully describe the works of some of the most renowned synthetic organic chemists of our time.
Graduate students, educators, and researchers in the fields of synthetic and medicinal chemistry will wish to have a copy of this book in their collection as an indispensable companion that both augments and extends the original Classics in Total Synthesis.
The accounts of these syntheses are presented with considerable attention to background, strategic ideas, new methodology and unusual chemistry. They are engaging, interesting and crystal clear. One cannot help but be impressed with the care and attention to detail that the authors have taken . . . The careful study of Classics in Total Synthesis I and II will help to show the way to the new synthesis of the future.
An excellent compendium that provides an insightful and authoritative coverage of demanding synthetic endeavors in such a way that they can be digested by the student, yet be enlightening for the more experienced reader . . . An excellent bargain that is highly recommended to everybody interested in advanced organic chemistry.
The arsenal of modern synthetic methodology is summarized in an amazing style and is extremely enjoyable to read . . . All chapters are presented in impressive clarity and even complex strategies are explained well.
Classics in Total Synthesis II is the long awaited sequel to Classics inTotal Synthesis. In this highly welcomed new volume, K. C. Nicolaou and Scott A.Snyder discuss in detail the most impressive accomplishments in natural producttotal synthesis during the 1990s and the first years of the 21st century.
domino reactions, cascade sequences, biomimetic strategies, andasymmetric catalysis are systematically developed through the chosen synthesis
cutting edge synthetic technologies are discussed in terms of mechanismand scope
new reactions, such as olefin metathesis, are presented in mini-reviewstyle
abundant references are given for further reading
Graduate students, educators, and researchers in the fields of syntheticand medicinal chemistry will wish to have a copy of this book in theircollection as an indispensable companion that both augments and supplements theoriginal Classics in Total Synthesis.
In the 90's further natural substances were synthesized for the firsttime in the laboratory and - still more importantly - new synthesismethods are now available, in order to revive older problems.Possibilities like the asymmetrical synthesis and ring-closingmetathesis were crucially developed further and are mentioned in theintroduction. They will be frequently met later in the concreteexamples.
The selected natural substances are again of general interest and theirsynthesis were explained in the same outstanding quality as in the firstvolume. Thus, we are hoping that further volumes will appear in the nextyears!
Dysidiolide (29, Scheme 6) was isolated from the marine sponge Dysidea etheria and found to have inhibitory activity toward protein phosphatase cdc25, with an IC50 value of 9.4 M [45]. This enzyme is a member of the protein family responsible for dephosphorylation of cyclin-dependent kinases [46]. Thus, inhibitors of cdc25 might allow for targeted cell-cycle disruption [45]. The relative stereochemistry of dysidiolide (29) was determined via single-crystal X-ray diffraction analysis, revealing a molecule with six stereocenters, two of which are quaternary carbons [45]. Several groups have reported total syntheses of this natural product [47-53], three of which are enantioselective [54-56].
The aspidosperma alkaloids have garnered much attention as beautiful targets for the synthetic chemist. Most of the 250-plus compounds in this class share a pentacyclic core, from the clinical anticancer therapeutics vincristine and vinblastine to the simpler aspidospermidine [60]. To address the challenging synthetic features of the aspidosperma alkaloids, many clever synthetic approaches have been reported [61,62]. One popular target in this family is aspidospermine (36, Scheme 8). Although its medicinal potency is inferior to other members of the class, this alkaloid has served as a proving ground for many synthetic chemists.
Quebrachamine (51) is an indole alkaloid isolated from the Aspidosperma quebracho tree bark [60]. It has been found to possess adrenergic blocking activities for a variety of urogenital tissues [85]. Structurally, it features a tetracycle including an indole nucleus, a 9-membered macrocycle, and an all-carbon quaternary stereocenter. Due to its structural complexity and biological activities, quebrachamine has received considerable attention from the chemistry community. A number of total syntheses have been reported [86-88], with several examples of asymmetric syntheses [89-91].
In 2007, Amat reported an enantioselective total synthesis of quebrachamine (Scheme 12) [92]. In their planning, disconnection at the macrocycle led to amide 52, which was prepared from 3,3-disubstituted piperidine 53. The all-carbon quaternary stereocenter in 53 was installed by double alkylation of lactam 55, using an auxiliary to control the stereoselectivity. We envisioned that an alternative way of constructing this motif would again make use of our recently developed palladium-catalyzed asymmetric alkylation of lactam enolates.
Vincadifformine (59) was isolated in both enantioenriched and racemic forms from the leaves and roots of Rhazya stricta in 1963 [93]. Not only is it a representative member of the Aspidosperma alkaloid family, but it also holds particular significance as a valuable precursor to pharmaceutically important vincamine, vincamone, and cavinton [94-97]. The molecule has a fused pentacyclic framework with three contiguous stereocenters, two of which are all-carbon quaternary centers. The medicinal relevance and structural complexity of vincadifformine have led to a large number of total syntheses [98-104], including several enantioselective examples [105-108].
Recently, Pandey reported a highly efficient synthesis of (+)-vincadifformine (Scheme 14) [106]. The key step in the synthesis was an iminium ion cascade reaction that formed the fused ring systems by coupling 3,3-disubstituted tetrahydropyridine 57 with indole derivative 58. The former coupling partner was derived from chiral α-quaternary lactam 60, which was constructed using a chiral auxiliary strategy. We envisioned that chiral lactam 60 could again be readily accessed by our palladium-catalyzed enantioselective alkylation chemistry.
We are grateful to NIH (R01GM080269), Amgen, the Gordon and Betty Moore Foundation, and Caltech for funding. We also thank the Caltech Minorities Undergraduate Research Fellowship program, PREM program, Eli Lilly, the Resnick Sustainability Institute at Caltech (fellowship for Y. L.), and the Swiss National Science Foundation (SNSF, fellowship for M. L.). Dr. Michael L. Krout and Dr. David E. White are acknowledged for preliminary experimental work related to their results. Dr. Michael Takase (Caltech) and Larry Henling (Caltech) are gratefully acknowledged for X-ray crystallographic structural determination.
2014 Liu et al; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: ( -journals.org/bjoc)
Total synthesis is the complete chemical synthesis of a complex molecule, often a natural product, from simple, commercially-available precursors.[1][2][3][4] It usually refers to a process not involving the aid of biological processes, which distinguishes it from semisynthesis. Syntheses may sometimes conclude at a precursor with further known synthetic pathways to a target molecule, in which case it is known as a formal synthesis. Total synthesis target molecules can be natural products, medicinally-important active ingredients, known intermediates, or molecules of theoretical interest. Total synthesis targets can also be organometallic or inorganic,[5][6] though these are rarely encountered. Total synthesis projects often require a wide diversity of reactions and reagents, and subsequently requires broad chemical knowledge and training to be successful.
Often, the aim is to discover a new route of synthesis for a target molecule for which there already exist known routes. Sometimes, however, no route exists, and chemists wish to find a viable route for the first time. Total synthesis is particularly important for the discovery of new chemical reactions and new chemical reagents, as well as establishing synthetic routes for medicinally important compounds.[7]
There are numerous classes of natural products for which total synthesis is applied to. These include (but are not limited to): terpenes, alkaloids, polyketides and polyethers.[8] Total synthesis targets are sometimes referred to by their organismal origin such as plant, marine, and fungal. The term total synthesis is less frequently but still accurately applied to the synthesis of natural polypeptides and polynucleotides. The peptide hormones oxytocin and vasopressin were isolated and their total syntheses first reported in 1954.[9] It is not uncommon for natural product targets to feature multiple structural components of several natural product classes.
7fc3f7cf58